<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158155">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02011893</url>
  </required_header>
  <id_info>
    <org_study_id>C-12-07</org_study_id>
    <nct_id>NCT02011893</nct_id>
  </id_info>
  <brief_title>SUNBURST (Success Using Neuromodulation With BURST) Study</brief_title>
  <acronym>SUNBURST</acronym>
  <official_title>Success Using Neuromodulation With BURST (SUNBURSTâ„¢) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for
      the treatment of chronic intractable pain of the trunk and/or limbs.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluation of stimulation-related adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change from baseline differences for average daily overall pain using the Visual Analog Scale (VAS) pain diary between Burst and Tonic Stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Disability</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paresthesia</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Responder rate</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Burst Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Burst Stimulation using the Prodigy system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tonic Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tonic Stimulation using the Prodigy system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tonic Stimulation</intervention_name>
    <description>Prodigy Neurostimulation System with associated components</description>
    <arm_group_label>Tonic Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Burst Stimulation</intervention_name>
    <description>Prodigy Neurostimulation System with associated components</description>
    <arm_group_label>Burst Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is 22 years of age or older

          -  Subject has chronic intractable pain of the trunk and/or limbs

          -  Subject has a average score of 60 or higher for average daily overall pain on the
             Visual Analog Scale (VAS) 7 day pain diary

          -  Subject has attempted &quot;best&quot; medical therapy and has tried and failed at least three
             documented medically supervised treatments (including, but not limited to physical
             therapy, acupuncture, etc.) and has failed medication treatment from at least two
             different classes

          -  Subject's pain-related medication regimen is stable 4 weeks prior to the baseline
             evaluation

          -  Subject agrees not to add or increase pain-related medication from activation through
             the 24 week follow-up visit

        Exclusion Criteria:

          -  Subject is currently participating in a clinical investigation that includes an
             active treatment arm

          -  Subject has been implanted with a previous neurostimulation system or participated in
             a trial period for a neurostimulation system

          -  Subject's overall Beck Depression Inventory II Score is &gt;24 or has a score of 3 on
             question 9 relating to suicidal thoughts or wishes at the screening visit

          -  Subject has an infusion pump or any implantable neurostimulator device

          -  Subjects with concurrent clinically significant or disabling chronic pain problem
             that requires additional treatment

          -  Subject has an existing medical condition that is likely to require repetitive MRI
             evaluation in the future (i.e. epilepsy, stroke, multiple sclerosis, acoustic
             neuroma, tumor)

          -  Subject has an existing medical condition that is likely to require the use of
             diathermy in the future

          -  Subject's pain originates from peripheral vascular disease

          -  Subject is immunocompromised

          -  Subject has documented history of allergic response to titanium or silicone

          -  Subject has a documented history of substance abuse (narcotics, alcohol, etc.) or
             substance dependency in the 6 months prior to baseline data collection

          -  Female candidates of child bearing potential that are pregnant (confirmed by positive
             urine/blood pregnancy test)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Deer, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Center for Pain Relief</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roni Diaz</last_name>
    <phone>972-309-8601</phone>
    <email>rdiaz@sjm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Newport Beach Headache and Pain</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Taghva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eisenhower Desert Orthopedic Center</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phillip Smith, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IPM Medical Group</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kasra Amirdelfan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Neuroscience Center</name>
      <address>
        <city>Ocean Springs</city>
        <state>Mississippi</state>
        <zip>39564</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bart Edmiston, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Comprehensive Pain &amp; Rehabilitation</name>
      <address>
        <city>Pascagoula</city>
        <state>Mississippi</state>
        <zip>39581</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Yearwood, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Montana Center for Wellness &amp; Pain Management</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>25301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camden Kneeland, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Pilitsis, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oklahoma Pain Physicians</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Justiz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NeuroSpine Institute</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Moore, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of South Carolina</name>
      <address>
        <city>North Charleston</city>
        <state>South Carolina</state>
        <zip>29406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Tavel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Center for Pain Relief</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Kim, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 22, 2014</lastchanged_date>
  <firstreceived_date>December 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
